Overview of implantable cardioverter-defibrillator in reducing total mortality in the high-risk coronary patient.

Research output: Contribution to journalArticle

Abstract

The idea of an implantable cardioverter-defibrillator (ICD) was conceived in the mid- to late 1960s, and working circuits were built and tested at Sinai Hospital of Baltimore in the fall of 1969. After a number of years of preclinical testing, the device entered clinical trials at The Johns Hopkins Hospital in February, 1980, and received Food and Drug Administration (FDA) approval in 1985. The device appeared to be highly effective, but there was criticism that it had not been tested in a randomized fashion, and there was the feeling that drugs would eventually prove to be superior. In 1989, a series of randomized clinical trials were begun. One of these trials, the Multicenter Automatic Defibrillator Implantation Trial (MADIT), has concluded and the outcome has recently been published. The results are landmark in importance and lead the way towards rational treatment of serious ventricular arrhythmia patients in clinical practice.

Original languageEnglish (US)
Pages (from-to)75-78
Number of pages4
JournalMaryland medical journal (Baltimore, Md. : 1985)
Volume46
Issue number2
StatePublished - 1997
Externally publishedYes

Fingerprint

Implantable Defibrillators
Drug Approval
Equipment and Supplies
Baltimore
Defibrillators
Mortality
United States Food and Drug Administration
Multicenter Studies
Cardiac Arrhythmias
Emotions
Randomized Controlled Trials
Clinical Trials
Pharmaceutical Preparations
Therapeutics

Cite this

@article{8eaa74967f69401d8c4fe0d54f58f1ec,
title = "Overview of implantable cardioverter-defibrillator in reducing total mortality in the high-risk coronary patient.",
abstract = "The idea of an implantable cardioverter-defibrillator (ICD) was conceived in the mid- to late 1960s, and working circuits were built and tested at Sinai Hospital of Baltimore in the fall of 1969. After a number of years of preclinical testing, the device entered clinical trials at The Johns Hopkins Hospital in February, 1980, and received Food and Drug Administration (FDA) approval in 1985. The device appeared to be highly effective, but there was criticism that it had not been tested in a randomized fashion, and there was the feeling that drugs would eventually prove to be superior. In 1989, a series of randomized clinical trials were begun. One of these trials, the Multicenter Automatic Defibrillator Implantation Trial (MADIT), has concluded and the outcome has recently been published. The results are landmark in importance and lead the way towards rational treatment of serious ventricular arrhythmia patients in clinical practice.",
author = "Mower, {Morton Maimon}",
year = "1997",
language = "English (US)",
volume = "46",
pages = "75--78",
journal = "Maryland Medical Journal",
issn = "1538-2656",
publisher = "Medical and Chirugical Faculty of Maryland",
number = "2",

}

TY - JOUR

T1 - Overview of implantable cardioverter-defibrillator in reducing total mortality in the high-risk coronary patient.

AU - Mower, Morton Maimon

PY - 1997

Y1 - 1997

N2 - The idea of an implantable cardioverter-defibrillator (ICD) was conceived in the mid- to late 1960s, and working circuits were built and tested at Sinai Hospital of Baltimore in the fall of 1969. After a number of years of preclinical testing, the device entered clinical trials at The Johns Hopkins Hospital in February, 1980, and received Food and Drug Administration (FDA) approval in 1985. The device appeared to be highly effective, but there was criticism that it had not been tested in a randomized fashion, and there was the feeling that drugs would eventually prove to be superior. In 1989, a series of randomized clinical trials were begun. One of these trials, the Multicenter Automatic Defibrillator Implantation Trial (MADIT), has concluded and the outcome has recently been published. The results are landmark in importance and lead the way towards rational treatment of serious ventricular arrhythmia patients in clinical practice.

AB - The idea of an implantable cardioverter-defibrillator (ICD) was conceived in the mid- to late 1960s, and working circuits were built and tested at Sinai Hospital of Baltimore in the fall of 1969. After a number of years of preclinical testing, the device entered clinical trials at The Johns Hopkins Hospital in February, 1980, and received Food and Drug Administration (FDA) approval in 1985. The device appeared to be highly effective, but there was criticism that it had not been tested in a randomized fashion, and there was the feeling that drugs would eventually prove to be superior. In 1989, a series of randomized clinical trials were begun. One of these trials, the Multicenter Automatic Defibrillator Implantation Trial (MADIT), has concluded and the outcome has recently been published. The results are landmark in importance and lead the way towards rational treatment of serious ventricular arrhythmia patients in clinical practice.

UR - http://www.scopus.com/inward/record.url?scp=0031066565&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031066565&partnerID=8YFLogxK

M3 - Article

C2 - 9029905

AN - SCOPUS:0031066565

VL - 46

SP - 75

EP - 78

JO - Maryland Medical Journal

JF - Maryland Medical Journal

SN - 1538-2656

IS - 2

ER -